Literature DB >> 17336518

Design, synthesis, and bioactivity of novel inhibitors of E. coli aspartate transcarbamoylase.

Joby Eldo1, Sabrina Heng, Evan R Kantrowitz.   

Abstract

A series of inhibitors of the aspartate transcarbamoylase, an enzyme involved in pyrimidine nucleotide biosynthesis, has been synthesized. These inhibitors are analogues of a highly potent inhibitor of this enzyme, N-phosphonacetyl-L-aspartate (PALA). Analogues have been synthesized with modifications at the alpha- and beta-carboxylates as well as at the aspartate moiety. The ability of these compounds to inhibit the enzyme was evaluated. These studies, with functional group modified PALA derivatives, showed that amide groups can be a useful substitute of the carboxylate in order to reduce the charge on the molecule, and indicate that the relative position of the functional group in the beta-position is more critical than the nature of the functional group. Some of the molecules synthesized here are potent inhibitors of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17336518      PMCID: PMC1930159          DOI: 10.1016/j.bmcl.2006.12.050

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  22 in total

1.  Pyrimidine pathways enzymes in human tumors of brain and associated tissues: potentialities for the therapeutic use of N-(phosphonacetyl-L-aspartate and 1-beta-D-arabinofuranosylcytosine.

Authors:  S Madani; J Baillon; J Fries; O Belhadj; A Bettaieb; M Ben Hamida; G Hervé
Journal:  Eur J Cancer Clin Oncol       Date:  1987-10

2.  Binding of radiolabeled N-(phosphonacetyl)-L-aspartate to aspartate transcarbamylase from Ehrlich ascites tumor cells.

Authors:  J C White; L H Hines
Journal:  Biochem Pharmacol       Date:  1984-11-15       Impact factor: 5.858

3.  Aspartate transcarbamylase. Interaction with the transition state analogue N-(phosphonacetyl)-L-aspartate.

Authors:  K D Collins; G R Stark
Journal:  J Biol Chem       Date:  1971-11       Impact factor: 5.157

4.  Comparative modeling of mammalian aspartate transcarbamylase.

Authors:  J L Scully; D R Evans
Journal:  Proteins       Date:  1991

5.  Efficient synthesis of fluorothiosparfosic acid analogues with potential antitumoral activity.

Authors:  Emmanuel Pfund; Thierry Lequeux; Serge Masson; Michel Vazeux; Alex Cordi; Alain Pierre; Valérie Serre; Guy Hervé
Journal:  Bioorg Med Chem       Date:  2005-08-15       Impact factor: 3.641

6.  Phosphorus-containing inhibitors of aspartate transcarbamoylase from Escherichia coli.

Authors:  N M Laing; W W Chan; D W Hutchinson; B Oberg
Journal:  FEBS Lett       Date:  1990-01-29       Impact factor: 4.124

7.  T-state inhibitors of E. coli aspartate transcarbamoylase that prevent the allosteric transition.

Authors:  Sabrina Heng; Kimberly A Stieglitz; Joby Eldo; Jiarong Xia; James P Cardia; Evan R Kantrowitz
Journal:  Biochemistry       Date:  2006-08-22       Impact factor: 3.162

8.  N-(Phosphonoacetyl)amino phosphonates. Phosphonate analogues of N-(phosphonoacetyl)-L-aspartic acid (PALA).

Authors:  P Kafarski; B Lejczak; P Mastalerz; D Duś; C Radzikowski
Journal:  J Med Chem       Date:  1985-11       Impact factor: 7.446

9.  Design and synthesis of new transition-state analogue inhibitors of aspartate transcarbamylase.

Authors:  G K Farrington; A Kumar; F C Wedler
Journal:  J Med Chem       Date:  1985-11       Impact factor: 7.446

10.  Synthesis and biochemical evaluation of adenosylspermidine, a nucleoside-polyamine adduct inhibitor of spermidine synthase.

Authors:  J R Lakanen; A E Pegg; J K Coward
Journal:  J Med Chem       Date:  1995-07-07       Impact factor: 7.446

View more
  2 in total

1.  Submicromolar phosphinic inhibitors of Escherichia coli aspartate transcarbamoylase.

Authors:  Laëtitia Coudray; Evan R Kantrowitz; Jean-Luc Montchamp
Journal:  Bioorg Med Chem Lett       Date:  2008-12-06       Impact factor: 2.823

2.  Synthesis and in vitro evaluation of aspartate transcarbamoylase inhibitors.

Authors:  Laëtitia Coudray; Anne F Pennebaker; Jean-Luc Montchamp
Journal:  Bioorg Med Chem       Date:  2009-09-30       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.